Corient Private Wealth’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$516K Buy
+78,488
New +$364K ﹤0.01% 2441

Other funds holding LFCR

Corient Private Wealth's LFCR Position: Q3 2026 in Review

Corient Private Wealth opened a new position in Lifecore Biomedical (LFCR) in Q3 2026: 78,488 shares worth $516K. The stake represents ﹤0.01% of the portfolio and ranks #2441 among its holdings.

105 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.

  • Corient Private Wealth held 78,488 shares of Lifecore Biomedical worth $516K as of Q3 2026.
  • Lifecore Biomedical was a new Corient Private Wealth position in Q3 2026.
  • Lifecore Biomedical made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #2441 holding.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.

Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.